- In July 2024, The Shanghai United Imaging Healthcare Co., LTD announced the installation of the first PET/CT scanner in Mexico, located at the Instituto Nacional de Pediatría
- In June 2024, GE Healthcare enhanced its technology portfolio with the introduction of the MINItrace Magni, a compact cyclotron designed for reliable in-house production of commercial PET tracers and radiometals; the Omni Legend 21 cm, a performance-driven PET/CT system aimed at addressing the increasing demands of healthcare systems across various care areas; and Clarify DL, a new deep learning reconstruction technology that provides clear, accurate, and seamless imaging
- In May 2023, Koninklijke Philips N.V., Elekta, and Mercurius Health announced a 3-year agreement, under which Philips and Elekta installed the diagnostic & therapeutic oncology equipment and aligned informatics solutions at Mercurius Health’s newly-acquired Robert Janker Klinik cancer center in Bonn, Germany
- In May 2024, Blue Earth Diagnostics, a Bracco company, has inked a non-exclusive data-sharing pact with Siemens Healthineers. The agreement covers the sharing of anonymized clinical data and images of POSLUMA® (previously 18F-rhPSMA-7.3) injection from Blue Earth Diagnostics' Phase 3 LIGHTHOUSE trial, focusing on newly diagnosed prostate cancer
- In March 2023, Positron Corporation signed a Clinical Study/Research Agreement with the Ochsner Clinic Foundation and Dr. Bober, Director of Molecular Imaging and Nuclear Cardiology at Ochsner Health. Under the agreement, the company and the organizations would carry out clinical studies of its new PET-CT imaging device, the Affinity PET-CT 4D
Frequently Asked Questions
The shift toward hybrid imaging modalities, is emerging as a pivotal trend driving the North America nuclear imaging devices market.
The major factors driving the growth of the nuclear imaging devices market are growing need due to rising incidence of chronic diseases.
The primary challenges include high cost and reimbursement issues and market dynamics challenging brand differentiation.
